HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
HC010 in First-line PD-L1 Positive Advanced NSCLC Patients
Recruiting · NCT07169552 · Registry updated 2025-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HC010 in First-line PD-L1 Positive Advanced NSCLC Patients | non-small cell lung carcinoma | Recruiting | Phase 2 | 2025-12-17 | NCT07169552 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HC Biopharma Inc. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai East Hospital | Shanghai | China | 17 |